Literature DB >> 150410

A case of the Sezary syndrome.

J G McCormack, P D Holland, D Pounder.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 150410     DOI： 10.1007/bf02939413

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  8 in total

1.  Sézary syndrome: treatment by leukophoresis.

Authors:  R S Tan; C J Oon; A J Barrett; J P Hayes; P D Samman
Journal:  Proc R Soc Med       Date:  1975-10

2.  Sezary's syndrome.

Authors:  W E ALDERSON; G I BARROW; R L TURNER
Journal:  Br Med J       Date:  1955-01-29

3.  Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis.

Authors:  R Edelson; M Facktor; A Andrews; M Lutzner; P Schein
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

4.  Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies.

Authors:  R L Edelson; C H Kirkpatrick; E M Shevach; P S Schein; R W Smith; I Green; M Lutzner
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

5.  Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome.

Authors:  J C Brouet; G Flandrin; M Seligmann
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

6.  Erythroderma with atypical lymphocytes. (Sézary syndrome).

Authors:  R K Winkelmann; J W Linman
Journal:  Am J Med       Date:  1973-08       Impact factor: 4.965

7.  Leukapheresis therapy of chronic lymphocytic leukemia.

Authors:  J E Curtis; E M Hersh; E J Freireich
Journal:  Blood       Date:  1972-02       Impact factor: 22.113

8.  Antilymphocyte globulin in the treatment of advanced Sézary syndrome.

Authors:  A J Barett; R C Staughton; D Brigden; N Byrom; J T Roberts; J R Hobbs
Journal:  Lancet       Date:  1976-05-01       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.